Aim immunotech selected to present at the 2nd annual marie sklodowska-curie symposium on cancer research and care

Ocala, fla., sept. 06, 2022 (globe newswire) -- aim immunotech inc. (nyse: american aim) (“aim” or the “company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including covid-19, the disease caused by the sars-cov-2 virus, today announced chris mcaleer, ph.d., deputy chief science officer of aim, and william mitchell, m.d. ph.d., chairman of the board of directors of aim, will present at the 2nd annual marie sklodowska-curie symposium on cancer research and care being held at the roswell park comprehensive cancer center in buffalo, n.y., september 8-10, 2022. in addition to management's presentations, the company is proud to announce its sponsorship of the event.
AIM Ratings Summary
AIM Quant Ranking